Results from the AVONEX® pregnancy registry published

Researchers affiliated to The AVONEX® Pregnancy Exposure Registry (Biogen) have published a case series of 306 pregnancy outcomes for a cohort of women with multiple sclerosis who used intramuscular interferon beta-1a during the first trimester. More information available here.

Photo by Mufid Majnun on Unsplash